Emalex. Revenue and Competitors
Estimated Revenue & Valuation
- Emalex.'s estimated annual revenue is currently $4.2M per year.
- Emalex.'s estimated revenue per employee is $155,000
Employee Data
- Emalex. has 27 Employees.
- Emalex. grew their employee count by 0% last year.
Emalex.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
3 | SVP - Legal Affairs and General Counsel | Reveal Email/Phone |
4 | VP, Chemistry, Manufacturing & Controls | Reveal Email/Phone |
5 | AVP Quality Assurance | Reveal Email/Phone |
6 | Senior Director, Clinical Operations | Reveal Email/Phone |
7 | Director Clinical Supply Chain | Reveal Email/Phone |
8 | Senior Director, Chemistry, Manufacturing and Controls | Reveal Email/Phone |
9 | Director, Drug Product Development | Reveal Email/Phone |
10 | Sr. Director, Clinical Operations | Reveal Email/Phone |
Emalex. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.6M | 17 | -6% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $2.5M | 16 | 0% | N/A | N/A |
#4 | $803.3M | 3239 | 9% | $1.79M | N/A |
#5 | $2.8M | 18 | 64% | N/A | N/A |
#6 | $38.4M | 248 | 18% | N/A | N/A |
#7 | $2M | 13 | -24% | N/A | N/A |
#8 | $1.4M | 9 | -25% | N/A | N/A |
#9 | $1.4M | 9 | 0% | N/A | N/A |
#10 | $2.5M | 16 | 7% | N/A | N/A |
What Is Emalex.?
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome. The latter is a childhood-onset neurodevelopmental condition characterized by motor and vocal tics for which very few safe and effective therapies exist.
keywords:N/A
N/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Emalex. News
("Emalex"), a biopharmaceutical company focused on developing treatments for central nervous system (CNS) movement disorders and fluency...
The new study was funded by Emalex Biosciences, LLC, maker of ecopipam. Gilbert's team randomly selected 149 youths, ages 6 to 17,...
The new study was funded by Emalex Biosciences, LLC, maker of ecopipam. RELATED Study: Electric current to the brain may help curb tics in...
Other Companies in Chicago
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 27 | -25% | $10M |
#2 | $6.1M | 27 | -10% | N/A |
#3 | $3.1M | 27 | N/A | N/A |
#4 | $2.7M | 27 | N/A | N/A |
#5 | $7.5M | 27 | 0% | $10M |